FDA Fast-Tracks Approval of Altria’s on! PLUS Nicotine Pouches Under New Pilot Program 
LG Energy Solution Shares Slide After Ford Cancels EV Battery Supply Deal 
U.S. Lawmakers Urge Pentagon to Blacklist More Chinese Tech Firms Over Military Ties 
Apple Opens iPhone to Alternative App Stores in Japan Under New Competition Law 
ANZ New CEO Forgoes Bonus After Shareholders Reject Executive Pay Report 
Trump Signals Push for Lower Health Insurance Prices as ACA Premium Concerns Grow 
Maersk Vessel Successfully Transits Red Sea After Nearly Two Years Amid Ongoing Security Concerns 
Elon Musk Wins Reinstatement of Historic Tesla Pay Package After Delaware Supreme Court Ruling 
Toyota to Sell U.S.-Made Camry, Highlander, and Tundra in Japan From 2026 to Ease Trade Tensions 
Dina Powell McCormick Resigns From Meta Board After Eight Months, May Take Advisory Role 
Micron Technology Forecasts Surge in Revenue and Earnings on AI-Driven Memory Demand 
Harris Associates Open to Revised Paramount Skydance Bid for Warner Bros Discovery 
Bridgewater Associates Plans Major Employee Ownership Expansion in Milestone Year 
Nike Shares Slide as Margins Fall Again Amid China Slump and Costly Turnaround 
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland 
Google and Apple Warn U.S. Visa Holders to Avoid International Travel Amid Lengthy Embassy Delays 
Oracle Stock Surges After Hours on TikTok Deal Optimism and OpenAI Fundraising Buzz 
JACKSONVILLE, Fla., March 01, 2016 -- ParkerVision, Inc. (NASDAQ:PRKR) (the “Company”) announced today that on February 29, 2016, it filed a petition for a Writ of Certiorari with the Supreme Court of the United States (“SCOTUS”) requesting a review of the decision of the United States Court of Appeals for the Federal Circuit in ParkerVision v. Qualcomm. ParkerVision is represented by Thomas C. Goldstein, Goldstein & Russell, P.C.
The question that ParkerVision is requesting the SCOTUS to review is “whether and under what circumstances an inconsistency in expert testimony permits a court to set aside a jury verdict and grant the losing party judgment as a matter of law.” A copy of the full petition can be found on ParkerVision’s website at: http://www.parkervision.com/company/public_relations/PatentCase_PDFs/PV_Q_USSC_05.pdf.
ParkerVision’s Chairman and Chief Executive Officer, Jeffrey Parker, commented, “The question posed in our Supreme Court petition is not only an important one for ParkerVision, but an important one for all plaintiffs, particularly innovators who have made significant investments in patented technologies, who believe their innovations are protected by the US patent system, and who rely on the Seventh Amendment guarantee of the right to trial by civil jury and the sanctity of the jury verdict to resolve patent disputes. The large number of jury verdicts reversed by the Federal Circuit in recent years contributes to an environment of uncertainty which threatens the future of innovation. We believe this is a critical issue in today’s patent environment, and the Supreme Court’s acceptance of our petition will be an indication that the highest court recognizes the importance of providing guidance on the appropriate role of the jury and the judge.”
About ParkerVision
ParkerVision, Inc. designs, develops and markets its proprietary radio-frequency (RF) technologies that enable advanced wireless solutions for current and next generation communications networks. Protected by a highly-regarded, worldwide patent portfolio, the Company’s solutions for wireless transfer of RF waveforms address the needs of a broad range of wirelessly connected devices for high levels of RF performance coupled with best-in-class power consumption. For more information please visit www.parkervision.com. (PRKR-G).
Safe Harbor Statement
This press release contains forward-looking information. Readers are cautioned not to place undue reliance on any such forward-looking statements, each of which speaks only as of the date made. Such statements are subject to certain risks and uncertainties which are disclosed in the Company's SEC reports, including the Form 10K for the year ended December 31, 2014 and Forms 10Q for the quarters ended March 31, June 30, and September 30, 2015. These risks and uncertainties could cause actual results to differ materially from those currently anticipated or projected.
Contact: Cindy Poehlman Chief Financial Officer ParkerVision, Inc. 904-732-6100, [email protected] or Don Markley The Piacente Group 212-481-2050, [email protected]
